Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T21:58:42.033Z.
Calculation as of: 2026-10-06T21:58:42.033Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5137b4856deab08b1171b62dbd6f0c7b956cbbc758e96459f42c43e497148cec
PE RATIO
N/A
PE RATIO AVG TTM
N/A
PE RATIO AVG 3Y
N/A
PE RATIO AVG 5Y
N/A
PE RATIO AVG 10Y
N/A
PE RATIO AVG 15Y
N/A
PE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$2.17B
PE Ratio
N/A
TTM Avg
6.84
3Y Avg
18.15
5Y Avg
20.42
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | $2.13B | N/A | N/A | N/A | N/A |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 19.85 | 21.19 | 24.83 | 28.15 |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | N/A | N/A | N/A | N/A |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | N/A | N/A | N/A | N/A |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | N/A | 6.84 | 18.15 | 20.42 |
| Pharvaris N.V. (PHVS)vs › | $2.17B | N/A | N/A | N/A | N/A |
| Alvotech (ALVO)vs › | $2.08B | N/A | 33.55 | 33.55 | 33.55 |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Celldex Therapeutics, Inc. (CLDX)vs › | $2.06B | N/A | N/A | N/A | N/A |
| Vericel Corporation (VCEL)vs › | $2.05B | 85.61 | 135.31 | 1187.07 | 1145.73 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$71.52
Forward EPS (Est.)
$0.10
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PE RATIO |
|---|---|
| 2026-02-23 | 1451.33 |
| 2026-02-20 | 1367.67 |
| 2026-02-19 | 1511.33 |
| 2026-02-18 | 1534.00 |
| 2026-02-17 | 1517.17 |
| 2026-02-13 | 1502.50 |
| 2026-02-12 | 1511.17 |
| 2026-02-11 | 1524.00 |
| 2026-02-10 | 1579.67 |
| 2026-02-09 | 1520.67 |
| 2026-02-06 | 1404.83 |
| 2026-02-05 | 1401.33 |
| 2026-02-04 | 1422.50 |
| 2026-02-03 | 1587.17 |
| 2026-02-02 | 1650.17 |
| 2026-01-30 | 1604.33 |
| 2026-01-29 | 1636.00 |
| 2026-01-28 | 1588.17 |
| 2026-01-27 | 1600.17 |
| 2026-01-26 | 1748.00 |
| 2026-01-23 | 1689.17 |
| 2026-01-22 | 1698.00 |
| 2026-01-21 | 1667.33 |
| 2026-01-20 | 1661.33 |
| 2026-01-16 | 1801.33 |
| 2026-01-15 | 1821.33 |
| 2026-01-14 | 1742.67 |
| 2026-01-13 | 1830.67 |
| 2026-01-12 | 1987.33 |
| 2026-01-09 | 2256.33 |
| 2026-01-08 | 2291.17 |
| 2026-01-07 | 2275.83 |
| 2026-01-06 | 2263.33 |
| 2026-01-05 | 2191.67 |
| 2026-01-02 | 2205.00 |
| 2025-12-31 | 2167.67 |
| 2025-12-30 | 2133.33 |
| 2025-12-29 | 2155.67 |
| 2025-12-26 | 2229.83 |
| 2025-12-24 | 2268.17 |
| 2025-12-23 | 2255.83 |
| 2025-12-22 | 2336.17 |
| 2025-12-19 | 2340.67 |
| 2025-12-18 | 2272.00 |
| 2025-12-17 | 2265.67 |
| 2025-12-16 | 2362.00 |
| 2025-12-15 | 2510.17 |
| 2025-12-12 | 2525.17 |
| 2025-12-11 | 2589.50 |
| 2025-12-10 | 2642.83 |
| 2025-12-09 | 2680.33 |
| 2025-12-08 | 2663.33 |
| 2025-12-05 | 2649.33 |
| 2025-12-04 | 2699.17 |
| 2025-12-03 | 2673.00 |
| 2025-12-02 | 2676.67 |
| 2025-12-01 | 2726.83 |
| 2025-11-28 | 2782.50 |
| 2025-11-26 | 2760.17 |
| 2025-11-25 | 2792.00 |
| 2025-11-24 | 2684.67 |
| 2025-11-21 | 2442.50 |
| 2025-11-20 | 2234.83 |
| 2025-11-19 | 2227.17 |
| 2025-11-18 | 2115.33 |
| 2025-11-17 | 2159.17 |
| 2025-11-14 | 2134.33 |
| 2025-11-13 | 2172.50 |
| 2025-11-12 | 2274.00 |
| 2025-11-11 | 2331.83 |
| 2025-11-10 | 2377.00 |
| 2025-11-07 | 2328.83 |
| 2025-11-06 | 2311.67 |
| 2025-11-05 | 2281.17 |
| 2025-11-04 | 2324.83 |
| 2025-11-03 | 2305.00 |
| 2025-10-31 | 2281.83 |
| 2025-10-30 | 2191.67 |
| 2025-10-29 | 2196.00 |
| 2025-10-28 | 6873.50 |
| 2025-10-27 | 6533.00 |
| 2025-10-24 | 6443.50 |
| 2025-10-23 | 6253.50 |
| 2025-10-22 | 6050.50 |
| 2025-10-21 | 6088.50 |
| 2025-10-20 | 6351.50 |
| 2025-10-17 | 6047.00 |
| 2025-10-16 | 5921.00 |
| 2025-10-15 | 5845.50 |
| 2025-10-14 | 6105.50 |
| 2025-10-13 | 6043.50 |
| 2025-10-10 | 6086.00 |
| 2025-10-09 | 6340.50 |
| 2025-10-08 | 6134.50 |
| 2025-10-07 | 6038.00 |
| 2025-10-06 | 6009.50 |
| 2025-10-03 | 5913.00 |
| 2025-10-02 | 5868.50 |
| 2025-10-01 | 5672.00 |
| 2025-09-30 | 5387.00 |
| 2025-09-29 | 5696.50 |
| 2025-09-26 | 5860.50 |
| 2025-09-25 | 5648.00 |
| 2025-09-24 | 5711.00 |
| 2025-09-23 | 6073.50 |
| 2025-09-22 | 6489.50 |
| 2025-09-19 | 6480.00 |
| 2025-09-18 | 6535.50 |
| 2025-09-17 | 6396.00 |
| 2025-09-16 | 6068.50 |
| 2025-09-15 | 6102.00 |
| 2025-09-12 | 6197.50 |
| 2025-09-11 | 6294.50 |
| 2025-09-10 | 6160.00 |
| 2025-09-09 | 6298.50 |
| 2025-09-08 | 6466.50 |
| 2025-09-05 | 6627.00 |
| 2025-09-04 | 6513.00 |
| 2025-09-03 | 6361.00 |
| 2025-09-02 | 6409.00 |
| 2025-08-29 | 6474.50 |
| 2025-08-28 | 6450.00 |
| 2025-08-27 | 6459.50 |
| 2025-08-26 | 6312.50 |
| 2025-08-25 | 6093.50 |
| 2025-08-22 | 6433.50 |
| 2025-08-21 | 6036.00 |
| 2025-08-20 | 6014.50 |
| 2025-08-19 | 6032.50 |
| 2025-08-18 | 6295.00 |
| 2025-08-15 | 6318.00 |
| 2025-08-14 | 6144.00 |
| 2025-08-13 | 6155.50 |
| 2025-08-12 | 5820.50 |
| 2025-08-11 | 5527.00 |
| 2025-08-08 | 5256.50 |
| 2025-08-07 | 5297.50 |
| 2025-08-06 | 5292.50 |
| 2025-08-05 | 5332.50 |
| 2025-08-04 | 5417.50 |
| 2025-08-01 | 5080.00 |
| 2025-07-31 | 5097.50 |
| 2025-07-30 | 5175.50 |
